NEW YORK, May 7 (GenomeWeb News) - Bio-Rad yesterday reported increased revenues but a drop in income for the first quarter of 2004.

 

Bio-Rad's revenues increased 8.4 percent year-over-year to $266.6 million in the quarter, from $246 million in the comparable quarter of 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.